2m 2m 2m 2m 2m 2m 2m
KRYSTAL BIOTECH (KRYS)
NASDAQ
$348.84+$1.83 (+0.53%)
Price as of Sep 11, 2026 7:30 PM EDT- $10.3BMarket Cap
- 141.51%1-Year Change
- BiotechnologyIndustry
KRYSTAL BIOTECH (KRYS)
$348.84+$1.83 (+0.53%)
KRYS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $347.00 | ||
Change | +$1.45 (+0.42%) | ||
Open | $349.59 | ||
High | $354.24 | ||
Low | $346.68 | ||
Previous Close | $345.55 | ||
Volume | 206,324 | ||
30-Day Average Volume | 219,062 | ||
1-Week Change | -3.14% | ||
1-Month Change | 6.10% | ||
1-Year Change | 141.51% | ||
3-Year Change | 170.17% | ||
5-Year Change | 498.28% | ||
Fundamentals | |||
Shares Outstanding | 29.6M | ||
Total Assets | $1.5B | ||
Market Cap | $10.3B | ||
Enterprise Value | $9.8B | ||
Period: QTR TTM FY | |||
Revenue | $119.2M | ||
Net Income | $54.8M | ||
Free Cash Flow | $71.2M | ||
EBIT | $66.1M | ||
EBITDA | $67.4M | ||
Net Working Capital | $932.3M | ||
EPS | $1.79 | ||
Enterprise Value/EBITDA | 146 | ||
Enterprise Value/Revenue | 83 | ||
P/B | 8 | ||
P/E | 194 | ||
PEG | -89 | ||
Price/Free Cash Flow | 144 | ||
Price/Operating Cash Flow | 137 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue